Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Revvity

< Previous 1 2 Next >
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Financial Results for the Third Quarter of 2025
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity Showcases Progress with Purpose in 2025 Impact Report
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Hold Earnings Call on Monday, October 27, 2025
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
From Revvity
Via Business Wire
Tickers RVTY
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
From Revvity
Via Business Wire
Tickers RVTY
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
From Revvity
Via Business Wire
Tickers RVTY
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Financial Results for the Second Quarter of 2025
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Hold Earnings Call on Monday, July 28, 2025
From Revvity
Via Business Wire
Tickers RVTY
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
From Revvity
Via Business Wire
Tickers RVTY
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Financial Results for the First Quarter of 2025
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity Fuels the Future of Cancer Science with New Research Solutions
From Revvity
Via Business Wire
Revvity to Hold Earnings Call on Monday, April 28, 2025
From Revvity
Via Business Wire
Tickers RVTY
Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
From Revvity
Via Business Wire
Tickers RVTY
Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery
From Revvity
Via Business Wire
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
From Revvity
Via Business Wire
Tickers RVTY
Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group
From Revvity
Via Business Wire
Tickers RVTY
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity Ignites Scientific Breakthroughs at SLAS2025
From Revvity
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.